Saudi Gazette report

RIYADH — Saudi Food and Drug Authority (SFDA) CEO Dr. Hisham Aljadhey started holding a series of meetings with international counterparts on the sidelines of the International Coalition of Medicines Regulatory Authorities (ICMRA) Summit 2025, which began in Amsterdam on Tuesday.

These include a meeting with Dr. Leandro Safatle, director-president of the Brazilian Health Regulatory Agency (ANVISA), and bilateral meetings with Dr. Ali El-Ghamrawy, chairman of the Egyptian Drug Authority (EDA), and with Lawrence Tallon, Chief Executive of the British Medicines and Healthcare Products Regulatory Authority (MHRA).

The discussions focused on strengthening cooperation and communication between regulatory authorities to achieve common goals and enhance the safety, quality, and efficacy of medicines and vaccines. They also reviewed leading practices and policies regarding artificial intelligence to promote innovation and growth in the pharmaceutical sector, in addition to several other topics of mutual interest.

ICMRA serves as an international platform for enhancing collaboration among regulatory bodies, addressing drug safety challenges with innovative mechanisms, and developing related regulations and systems. This aligns with the objectives of the health sector transformation program within the Kingdom's Vision 2030.